July 16, 2004, Hour One: HIV/AIDS Update / Gleevec Update

Science Friday > Archives > 2004 > July > July 16, 2004:
Hour One: HIV/AIDS Update / Gleevec Update

Thousands of scientists, activists, and policy makers are meeting in Bangkok, Thailand this week for the International AIDS Conference. In this hour of Science Friday, join guest host Joe Palca for an update from the meeting, including a look at the latest in AIDS treatment and prevention. Are microbicide gels the best option for preventing HIV infection in women? What are the prospects for an HIV vaccine?

Plus, we'll find out about a new source of hope for leukemia patients whose cancer is resistant to the drug Gleevec. Call in with your questions and comments at 1-800-989-8255 (2-3 Eastern), and share your opinions online in our Listeners' Lounge (registration required).

Guests:
Richard Knox
Correspondent
National Public Radio
Boston, Massachusetts

Gary Nabel
Director, Vaccine Research Center
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Bethesda, Maryland

Paul A. Volberding
Professor and Vice Chair of the Department of Medicine
Director, Center for AIDS Research
University of California, San Francisco
Chief of Medical Service, San Francisco Veterans Affairs Medical Center
San Francisco, California

****************************************************************************

Charles L. Sawyers
Howard Hughes Medical Institute Investigator
UCLA Jonsson Comprehensive Cancer Center
Peter Bing Professor
Department of Medicine, Urology, and Pharmacology
University of California, Los Angeles
Los Angeles, California

This segment produced by Annette Heist and Erica Altman

Archived Audio:
AIDS/HIV
listen in RealAudio format
listen in Windows Media format

Gleevec
listen in RealAudio format
listen in Windows Media format
streaming audio help from NPR

Books/Articles Discussed:

(find books discussed on previous broadcasts)